Linezolid population pharmacokinetics in South African adults with drug-resistant tuberculosis

CONCLUSION Our model characterised population pharmacokinetics of linezolid in South African patients with DR-TB and supports the 600 mg daily dose with safety monitoring.PMID:34543098 | DOI:10.1128/AAC.01381-21

Source: Antimicrobial Agents and Chemotherapy - September 20, 2021 Category: Microbiology Authors: Mahmoud Tareq Abdelwahab Sean Wasserman James C M Brust Keertan Dheda Lubbe Wiesner Neel R Gandhi Robin M Warren Frederick A Sirgel Graeme Meintjes Gary Maartens Paolo Denti Source Type: research